- Home
- SYRE vs IDCC Comparison
SYRE vs IDCC Comparison
Compare SYRE & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | IDCC |
|---|---|---|
| Founded | 2013 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.6B |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SYRE | IDCC |
|---|---|---|
| Price | $86.72 | $295.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $85.08 | ★ $412.50 |
| AVG Volume (30 Days) | ★ 892.9K | 344.0K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | ★ $307,404,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.38 |
| P/E Ratio | ★ N/A | $133.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.49 | $213.06 |
| 52 Week High | $88.03 | $412.60 |
Technical Indicators
Market Signals| Indicator | SYRE | IDCC |
|---|---|---|
| Relative Strength Index (RSI) | 67.73 | 63.28 |
| Support Level | $66.78 | $249.31 |
| Resistance Level | N/A | $365.98 |
| Average True Range (ATR) | 4.83 | 11.08 |
| MACD | 1.12 | 6.42 |
| Stochastic Oscillator | 82.70 | 94.61 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.